Draft Guidelines For Biosimilar Product Development News Today : Breaking News, Live Updates & Top Stories | Vimarsana

It's always good to have a villain, a "Snidely Whiplash" or other cartoon caricature to support an argument, especially if the issue is complex and fails the cocktail party test.

New yorkUnited statesAmgen neupogenAmjevita amgenSandoz filgrastim biosimilarProfessor adam mossoff at george mason universityNew york timesDraft guidelines for biosimilar product developmentAbbvie incCity council of baltimoreCircuit courtThenew york timesYork times reopens attackBiologic price competitionInnovation actBiologics news briefs